ICON Receives Finalist Nomination for the 2015 Scrip Awards
Firecrest eConsent shortlisted in best technological development in Clinical Trials category.
ICON and IBM to Revolutionise Clinical Trials
ICON applies IBM Watson clinical trial matching to oncology clinical trials.
ICON Launches Medical Device & Diagnostics Research Group
Dedicated services to support medical device manufacturers throughout the product lifecycle.
ICON Completes Acquisition of MediMedia Pharma Solutions
Extends ICON’s leadership in commercialisation and market access services and brings new scientific communications capabilities
ICON Launches Electronic Informed Consent
Part of ICONIK Informatics Hub to enhance patient engagement in the trial process, in line with FDA guidelines.
ICON and Carnegie Mellon Collaborating on Informed Consent
ICON and Carnegie Mellon University Collaborate to Evaluate Patient-centric Informed Consent Processes
ICON Reports Fourth Quarter and Full Year 2014 Results and Issues 2015 Earnings Guidance
In the fourth quarter net revenue grew 13.0% year on year to $390.
ICON to Acquire MediMedia Pharma Solutions
The acquisition strengthens ICON’s expertise in scientific communications and market access
ICON Creates New Global Innovation Hub to Advance Clinical Development
The hub will create 200 scientific, IT and business jobs in Ireland
ICON Launches Innovative Safety Application
Real-time data enables physicians to respond faster to safety signals.